HCSGD entry for IL4
1. General information
Official gene symbol | IL4 |
---|---|
Entrez ID | 3565 |
Gene full name | interleukin 4 |
Other gene symbols | BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0002227 | Innate immune response in mucosa | IEA | biological_process |
GO:0002296 | T-helper 1 cell lineage commitment | IEA | biological_process |
GO:0002674 | Negative regulation of acute inflammatory response | IEA | biological_process |
GO:0002677 | Negative regulation of chronic inflammatory response | IEA | biological_process |
GO:0005125 | Cytokine activity | IEA | molecular_function |
GO:0005136 | Interleukin-4 receptor binding | TAS | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005615 | Extracellular space | TAS | cellular_component |
GO:0006935 | Chemotaxis | TAS | biological_process |
GO:0006955 | Immune response | TAS | biological_process |
GO:0006968 | Cellular defense response | TAS | biological_process |
GO:0007565 | Female pregnancy | IEA | biological_process |
GO:0007584 | Response to nutrient | IEA | biological_process |
GO:0008083 | Growth factor activity | NAS | molecular_function |
GO:0008203 | Cholesterol metabolic process | ISS | biological_process |
GO:0009897 | External side of plasma membrane | IEA | cellular_component |
GO:0010155 | Regulation of proton transport | IEA | biological_process |
GO:0014070 | Response to organic cyclic compound | IEA | biological_process |
GO:0030183 | B cell differentiation | TAS | biological_process |
GO:0030890 | Positive regulation of B cell proliferation | ISS | biological_process |
GO:0031296 | B cell costimulation | IEA | biological_process |
GO:0032733 | Positive regulation of interleukin-10 production | IEA | biological_process |
GO:0032736 | Positive regulation of interleukin-13 production | IDA | biological_process |
GO:0034097 | Response to cytokine | IEA | biological_process |
GO:0035745 | T-helper 2 cell cytokine production | IDA | biological_process |
GO:0042092 | Type 2 immune response | TAS | biological_process |
GO:0042102 | Positive regulation of T cell proliferation | ISS | biological_process |
GO:0042104 | Positive regulation of activated T cell proliferation | IEA | biological_process |
GO:0042325 | Regulation of phosphorylation | ISS | biological_process |
GO:0042493 | Response to drug | IEA | biological_process |
GO:0042523 | Positive regulation of tyrosine phosphorylation of Stat5 protein | IEA | biological_process |
GO:0042832 | Defense response to protozoan | IEA | biological_process |
GO:0043031 | Negative regulation of macrophage activation | IEA | biological_process |
GO:0043066 | Negative regulation of apoptotic process | ISS | biological_process |
GO:0045019 | Negative regulation of nitric oxide biosynthetic process | IEA | biological_process |
GO:0045064 | T-helper 2 cell differentiation | IEA | biological_process |
GO:0045080 | Positive regulation of chemokine biosynthetic process | IEA | biological_process |
GO:0045189 | Connective tissue growth factor biosynthetic process | TAS | biological_process |
GO:0045191 | Regulation of isotype switching | TAS | biological_process |
GO:0045348 | Positive regulation of MHC class II biosynthetic process | ISS | biological_process |
GO:0045471 | Response to ethanol | IEA | biological_process |
GO:0045582 | Positive regulation of T cell differentiation | IDA | biological_process |
GO:0045671 | Negative regulation of osteoclast differentiation | ISS | biological_process |
GO:0045892 | Negative regulation of transcription, DNA-templated | IDA | biological_process |
GO:0045893 | Positive regulation of transcription, DNA-templated | IDA | biological_process |
GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | ISS | biological_process |
GO:0048295 | Positive regulation of isotype switching to IgE isotypes | ISS | biological_process |
GO:0048304 | Positive regulation of isotype switching to IgG isotypes | ISS | biological_process |
GO:0050776 | Regulation of immune response | ISS | biological_process |
GO:0051091 | Positive regulation of sequence-specific DNA binding transcription factor activity | IEA | biological_process |
GO:0071288 | Cellular response to mercury ion | IEA | biological_process |
GO:0097028 | Dendritic cell differentiation | IDA | biological_process |
GO:0097192 | Extrinsic apoptotic signaling pathway in absence of ligand | IEA | biological_process |
GO:2000320 | Negative regulation of T-helper 17 cell differentiation | IEA | biological_process |
GO:2001237 | Negative regulation of extrinsic apoptotic signaling pathway | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.8939408685 | 0.5630904791 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Down | -0.0598011854 |
GSE13712_SHEAR | Down | -0.0810395686 |
GSE13712_STATIC | Down | -0.0267508844 |
GSE19018 | Down | -0.0294303844 |
GSE19899_A1 | Down | -0.0120563755 |
GSE19899_A2 | Up | 0.0263924711 |
PubMed_21979375_A1 | Up | 0.4067235002 |
PubMed_21979375_A2 | Up | 0.2175743852 |
GSE35957 | Up | 0.1000003129 |
GSE36640 | Down | -0.0338285367 |
GSE54402 | Up | 0.0568585129 |
GSE9593 | Up | 0.0391175974 |
GSE43922 | Up | 0.0133152163 |
GSE24585 | Up | 0.1698634287 |
GSE37065 | Down | -0.0794671872 |
GSE28863_A1 | Down | -0.1590180587 |
GSE28863_A2 | Down | -0.1330252836 |
GSE28863_A3 | Up | 0.0810719016 |
GSE28863_A4 | Down | -0.3315621392 |
GSE48662 | Down | -0.0104912539 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-335-5p | MIMAT0000765 | MIRT018167 | Microarray | Functional MTI (Weak) | 18185580 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 13 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
26434982 | We found not only an age-dependent increase in expression of several pro-inflammatory mediators, but also activation of a strong anti-inflammatory response involving enhanced IL4/IL10 expression and immune skewing toward a Th2 response |
25989853 | By contrast, in consequence of impaired nuclear translocation of phospho-STAT6, genes involved in IL-4 induced alternative activation were strongly downregulated |
25989853 | Functionally, impaired actin dynamics resulted in reduced NO secretion and reduced release of TNFalpha and IL-6 from LPS-stimulated microglia and of IGF-1 from IL-4 stimulated microglia |
25466460 | The SPR biosensor also shows specificity for IGFBP7 compared to that for biologically relevant interleukin (IL) derivatives including IL4, IL23, IL29, and IFG1 |
24434012 | Multiplex analysis revealed that multiple cytokines are increased in BPH, including GM-CSF, IL-1alpha, and IL-4, and that these are also increased in senescent prostatic epithelial cells in vitro |
23935100 | Interleukin (IL)-4, originally identified as a lymphocyte growth factor, can directly inhibit growth of certain tumor cell types |
23935100 | Both of these molecules were activated by 10 min after IL-4 treatment, and inhibition of their activity or expression prevented growth suppression and cellular senescence induced by IL-4 |
18206261 | TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells |
18206261 | In a previous study, we demonstrated the inhibitory activity of several cytokines on the HPV-16 long control region (LCR)-driven transcription; among these, IL-4 was reported as a LCR inhibitor for the first time and proposed as a candidate for further studies |
18206261 | Here, we addressed the question of whether IL-4 represses HPV-16 oncogene transcription and exerts antitumor activity in HPV-16 positive cervical carcinoma cell lines |
18206261 | Results indicated that downregulation of E6 and E7 levels by IL-4 in CaSki cells is weaker than that exerted by TGF-beta1, a known LCR inhibitor, although both cytokines are equally active in suppressing LCR-driven transcriptional activity in a reporter cell line |
16821141 | In inflamed portal tracts of PBC, CD4+ T cells of Th1 type expressing IFN-gamma or CXCR3 are aggregated and more commonly detected around injured bile ducts than Th2-type CD4+ T cells expressing IL-4 or CCR4, indicating that Th1-dominant cellular immunity plays a more-prominent role in recruitment of memory T-cell subsets in PBC and may be responsible for the progressive bile duct damage |
15876845 | After culture in vitro, these cells shown increase susceptibility to undergoing spontaneous apoptosis, that is enhanced by IL-4 and prevented by IL-1beta or LPS |
15685514 | Expression of p53, CD14/CD16, and intracellular cytokine production (interleukin-1beta [IL-1beta], IL-6, and IL-4) was evaluated by means of flow cytometry using specific antibodies |
15685514 | RESULTS: Features of senescence were found in a subpopulation of mononuclear cells: (1) accelerated telomere shortening, (2) increased p53 expression, (3) CD14dim/CD16bright expression, and (4) cytokine overproduction (IL-1beta, IL-6, and IL-4) |
11872952 | METHODS: T cell cultures were established from colonic biopsy specimens of 27 patients with Crohn's disease and from 10 healthy controls in a medium supplemented with IL-2 and IL-4 but without addition of exogenous antigen or mitogen |
11830522 | IL-10 and IL-4 mRNA expression was not significantly different from control samples |
9691202 | However, continuous T lymphocyte cell lines can often be established from chronic inflammatory skin diseases when the culture medium is supplemented with IL-2 and IL-4 but without antigen and accessory cells added |
9691202 | Withdrawal of either IL-2 or IL-4 results in cell growth arrest concomitant with down-regulation of telomerase activity |
1477651 | The role of IL-4 in human myeloid leukemia: stimulation of RNA synthesis and transduction of differentiation signals through an IL-4 receptor leads to functional and HLA positive HL-60 cells |
1477651 | One example, that is the subject of this study, is the presence of the interleukin-4 (IL-4) receptor on the surface of the human HL-60 myeloid leukemia cell line |
1477651 | The presence of such a receptor, that at first seems to be a simple genetic misprogramming, has an unusual biological function: It serves as a bridge to link the B cell growth factor IL-4 in order to transduce a number of differentiation signals in this M2 acute myeloid leukemia (AML) population |
1477651 | Daily administration of low IL-4 dose yields proliferative senescent cells that exhibit 66% of growth inhibition in a 5-day tritiated thymidine incorporation assay |
1477651 | Cellular function is also affected positively since phagocytosis of latex beads increases considerably after IL-4 treatment |
Entries Per Page
Displaying Page of